biomedcentral | Variation
in the human fecal microbiota has previously been associated with body
mass index (BMI). Although obesity is a global health burden, the
accumulation of abdominal visceral fat is the specific cardio-metabolic
disease risk factor. Here, we explore links between the fecal microbiota
and abdominal adiposity using body composition as measured by
dual-energy X-ray absorptiometry in a large sample of twins from the
TwinsUK cohort, comparing fecal 16S rRNA diversity profiles with six
adiposity measures.
Results
We profile six adiposity
measures in 3666 twins and estimate their heritability, finding novel
evidence for strong genetic effects underlying visceral fat and
android/gynoid ratio. We confirm the association of lower diversity of
the fecal microbiome with obesity and adiposity measures, and then
compare the association between fecal microbial composition and the
adiposity phenotypes in a discovery subsample of twins. We identify
associations between the relative abundances of fecal microbial
operational taxonomic units (OTUs) and abdominal adiposity measures.
Most of these results involve visceral fat associations, with the
strongest associations between visceral fat and Oscillospira
members. Using BMI as a surrogate phenotype, we pursue replication in
independent samples from three population-based cohorts including
American Gut, Flemish Gut Flora Project and the extended TwinsUK cohort.
Meta-analyses across the replication samples indicate that 8 OTUs
replicate at a stringent threshold across all cohorts, while 49 OTUs
achieve nominal significance in at least one replication sample.
Heritability analysis of the adiposity-associated microbial OTUs
prompted us to assess host genetic-microbe interactions at
obesity-associated human candidate loci. We observe significant
associations of adiposity-OTU abundances with host genetic variants in
the FHIT, TDRG1 and ELAVL4 genes, suggesting a potential role for host genes to mediate the link between the fecal microbiome and obesity.
Conclusions
Our results provide novel
insights into the role of the fecal microbiota in cardio-metabolic
disease with clear potential for prevention and novel therapies.
0 comments:
Post a Comment